Market revenue in 2023 | USD 151.6 million |
Market revenue in 2030 | USD 225.7 million |
Growth rate | 5.8% (CAGR from 2023 to 2030) |
Largest segment | Biologics |
Fastest growing segment | Biologics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications |
Key market players worldwide | ConvaTec Group PLC, 3M Co, Coloplast A/S ADR, Smith & Nephew PLC, Medtronic PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetic foot ulcer treatment market will help companies and investors design strategic landscapes.
Biologics was the largest segment with a revenue share of 36.48% in 2023. Horizon Databook has segmented the Italy diabetic foot ulcer treatment market based on wound care dressings, biologics, therapy devices, antibiotic medications covering the revenue growth of each sub-segment from 2018 to 2030.
The presence of well-developed healthcare services in Italy is one of the major driving factors for the market growth. Services such as National Health Service (NHS) in Italy cover all citizens and foreign residents for healthcare services. For instance, as per Commonwealth Fund, public financing in Italy accounted for 75.8% of total health spending.
Additionally, an increase in diabetic population in Italy is expected to drive the market. For instance, according to International Diabetes Federation, the prevalence of diabetes in Italy is 8.3% of the total population. The total number of diabetic adults in the country was estimated to be 3,669,400 in 2020.
The increase in diabetic patients may further increase the prevalence of diabetic foot ulcers, which require regular wound dressings. Thus, with the increase in the prevalence of diabetes in Italy, the market is anticipated to witness significant growth over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy diabetic foot ulcer treatment market , including forecasts for subscribers. This country databook contains high-level insights into Italy diabetic foot ulcer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account